- Chart
- Upturn Summary
- Fund Details
Upturn AI Summary
Global X Aging Population ETF(AGNG)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for AGNG
11/20/2026: AGNG (1-star) has a low Upturn Star Rating. Not recommended to BUY.
The Global X Aging Population ETF (AGNG) provides targeted exposure to global companies positioned to benefit from the growing senior demographic, spanning pharmaceuticals, medical devices, healthcare services, and senior living facilities. It achieves this via a passive replication strategy tracking the Indxx Aging Population Thematic Index with standard diversification caps. Its primary strengths lie in its pure-play thematic design and global developed market reach, making it a fitting satellite allocation for investors seeking long-term secular growth. Key risks include sector concentration, healthcare regulatory pressures, and moderate liquidity relative to broad-market funds. It is best suited for growth-oriented investors willing to accept sector-specific volatility in exchange for demographic-driven upside.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
ETF holdings, costs, diversification, valuation, risks, and market conditions provide supporting context about the fund.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | Suited for investors looking to capture long-term structural growth driven by global demographic aging trends. |
| Momentum investor | Strong fit while signal remains positive | Can capture strong upward momentum during periods of outperformance in healthcare and biotechnology sectors. |
| Value investor | Mixed fit | Many constituent holdings trade at elevated valuations given their growth and R&D focus. |
| Dividend/Income investor | Mixed fit | While some holdings pay steady dividends, the fund prioritizes thematic capital appreciation over high current yield. |
| Low-risk investor | Weak fit | Subject to sector-specific regulatory, clinical trial, and equity market volatility. |
Investor Profile
Ideal Investor Profile
Long-term investors seeking targeted thematic exposure to the secular growth trends arising from global population aging and increased healthcare longevity.
Suitability
Best utilized as a satellite holding within a diversified long-term portfolio rather than a core passive index holding.
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Volatility | Medium / high | Thematic exposure to healthcare and biotechnology can experience sharp price swings based on sentiment and regulatory updates. |
| Market risk | High | As an equity fund, it is fully exposed to broad stock market downturns and systemic financial shocks. |
| Concentration | Medium | Concentrated specifically in industries serving the aging demographic rather than the broader broad-market economy. |
| Tracking/expense | Low | An expense ratio of 0.50% and effective index replication keep tracking errors minimal. |
| Liquidity | Medium | Moderate assets under management mean trading blocks should be executed carefully to avoid wider spreads. |
| Business/sector quality | Medium / high | Relies heavily on the fundamental health, regulatory approvals, and financial stability of global healthcare enterprises. |
Sector & Industry Intelligence
This fund is not assigned to one sector.
Risk Analysis
Volatility
AGNG demonstrates moderate-to-high historical volatility typical of thematic equity funds that concentrate in growth-oriented healthcare and pharmaceutical sub-sectors.
Market Risk
The fund is subject to risks tied to equity market cycles, healthcare policy changes, clinical trial outcomes, and macroeconomic sentiment affecting growth valuations.
What the ETF Owns
| Exposure Type | Exposure | Weight (%) | Retail Investor Read |
|---|---|---|---|
| Single stock | Eli Lilly and Company (LLY) | 4.04 | Provides top-tier exposure to leading pharmaceutical developments addressing age-related chronic conditions. |
| Single stock | AbbVie Inc. (ABBV) | 3.72 | Offers diversified exposure to major therapeutics and immunology treatments heavily utilized by older populations. |
| Sector | Healthcare Products, Pharmaceuticals, and Medical Devices | 55 | Captures the core medical and therapeutic equipment providers driving longevity and medical advancements. |
| Industry | Senior Living Facilities and Specialized Real Estate (WELL, VTR) | 15 | Provides direct exposure to senior housing and healthcare real estate serving an expanding aging society. |
| Geography | Global Developed Markets (US, Europe, Japan) | 25.24 | Ensures broad geographic diversification across advanced economies experiencing rapid demographic aging. |
Price Behavior

Steady Uptrend
The stock demonstrates consistent and steady upward price momentum.

Very Smooth
The stock has followed a highly orderly price path with minimal short-term disruption.
Analysis of Past Performance
Type ETF | Historic Profit 39.6% | Avg. Invested days 85 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | ETF Returns Performance |

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

